Mutations in phospholipase C eta-1 (PLCH1) are associated with holoprosencephaly.
Christopher Geoffrey WoodsEmily FletcherRanad ShaheenMichael NahorskiAmal M AlhashemSteven N LisgoAlberto Fernández JaénKatherine SchonKalthoum Tlili-GraiessSarah F SmithsonSusan LindsayHayley J SharpeFowzan Sami AlkurayaPublished in: Journal of medical genetics (2021)
Our data support the contention that PLCH1 has a role in prenatal mammalian neurodevelopment, and deleterious variants cause a clinically variable holoprosencephaly spectrum phenotype.